- Home
- PYXS vs MASS Comparison
PYXS vs MASS Comparison
Compare PYXS & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYXS
- MASS
- Stock Information
- Founded
- PYXS 2018
- MASS 2012
- Country
- PYXS United States
- MASS United States
- Employees
- PYXS N/A
- MASS N/A
- Industry
- PYXS Biotechnology: Pharmaceutical Preparations
- MASS Medical/Dental Instruments
- Sector
- PYXS Health Care
- MASS Health Care
- Exchange
- PYXS Nasdaq
- MASS Nasdaq
- Market Cap
- PYXS 76.1M
- MASS 84.3M
- IPO Year
- PYXS 2021
- MASS 2020
- Fundamental
- Price
- PYXS $1.28
- MASS $2.53
- Analyst Decision
- PYXS Strong Buy
- MASS Buy
- Analyst Count
- PYXS 6
- MASS 3
- Target Price
- PYXS $9.20
- MASS $5.33
- AVG Volume (30 Days)
- PYXS 551.2K
- MASS 298.0K
- Earning Date
- PYXS 03-20-2025
- MASS 03-04-2025
- Dividend Yield
- PYXS N/A
- MASS N/A
- EPS Growth
- PYXS N/A
- MASS N/A
- EPS
- PYXS N/A
- MASS N/A
- Revenue
- PYXS $16,146,000.00
- MASS $55,162,000.00
- Revenue This Year
- PYXS N/A
- MASS $15.31
- Revenue Next Year
- PYXS N/A
- MASS $16.10
- P/E Ratio
- PYXS N/A
- MASS N/A
- Revenue Growth
- PYXS N/A
- MASS 16.08
- 52 Week Low
- PYXS $1.23
- MASS $1.81
- 52 Week High
- PYXS $6.85
- MASS $7.91
- Technical
- Relative Strength Index (RSI)
- PYXS 32.91
- MASS 49.72
- Support Level
- PYXS $1.23
- MASS $2.29
- Resistance Level
- PYXS $1.40
- MASS $3.05
- Average True Range (ATR)
- PYXS 0.09
- MASS 0.25
- MACD
- PYXS 0.00
- MASS 0.01
- Stochastic Oscillator
- PYXS 15.15
- MASS 33.33
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.